author-photo

Robert R. Henry

University of California, San Diego

373

Papers

28899

Citations

Citation Trend

Filter By

Papers (269) Sort By

Journal Conference Others

Impaired capillary tube formation induced by elevated secretion of IL8 involves altered signaling via the CXCR1/PI3K/MMP2 pathway.

2021 Molecular Biology Reports
Show All
- Source
- Cite
- Save
Citations (0)
Umstellung auf iGlarLixi gegenüber der weitergeführten Behandlung mit einem GLP-1-Rezeptoragonisten bei unzureichend kontrolliertem Typ-2-Diabetes: die randomisierte LixiLan-G-Studie

2021
Show All
- Source
- Cite
- Save
Citations (0)
Alirocumab offers superior benefits to usual care in treating high-risk patients with type 2 diabetes

2020
Show All
- Source
- Cite
- Save
Citations (1)
SUN-670 P300 and CBP Are Necessary for Skeletal Muscle Insulin-Stimulated Glucose Uptake

2020 Journal of the Endocrine Society
Show All
- Source
- Cite
- Save
Citations (0)
Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity.

2020 Nature Communications
Show All
- Source
- Cite
- Save
Citations (16)
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes

2019 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (59)
149-OR: LixiLan-G: A Randomized Trial Assessing Switching to iGlarLixi vs. Continuation of Daily or Weekly GLP-1RA in T2D Inadequately Controlled by a GLP-1RA and OAD(s)

2019 Diabetes
Show All
- Source
- Cite
- Save
Citations (1)
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated with Sodium-Glucose Cotransporter (SGLT) Inhibitors

2019 Diabetes Care
Show All
- Source
- Cite
- Save
Citations (121)
1139-P: Influence of Screening HbA1c Levels on Glucose Control Achieved when Switching to iGlarLixi in T2D Inadequately Controlled on GLP-1RA and OAD(s)

2019 Diabetes
Show All
- Source
- Cite
- Save
Citations (1)
1146-P: Switching to iGlarLixi vs. Continued Treatment of GLP-1RA: Comparative Analysis by Daily or Weekly GLP-1RAs in the LixiLan-G Trial

2019 Diabetes
Show All
- Source
- Cite
- Save
Citations (0)